Business Segments Clinuvel Pharmaceuticals Limited Deutsche Boerse AG
Stocks
UR9
AU000000CUV3
Pharmaceuticals
|
Real-time Estimate
Tradegate
14:52:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 5.220 EUR | -1.51% |
|
-8.62% | -24.29% |
| 08-28 | Morgans Financial Downgrades Clinuvel Pharmaceuticals to Hold from Speculative Buy; Price Target is AU$10 | MT |
| 08-27 | Clinuvel Pharmaceuticals Limited, 2026 Earnings Call, Aug 27, 2026 |
Sales 2026 by Business Segment
Sales 2026 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: June | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Biopharmaceutical Sector | 66.17M | 78.32M | 88.18M | 95.02M | 94.02M | |||||
Total Assets | 144M | 194M | 231M | 272M | - | |||||
Interest Expense | -2.27M | -3.19M | -4.45M | -4.46M | - | |||||
Income Tax Expense | 13.44M | 14.97M | 15.04M | 15.38M | 13.74M | |||||
CAPEX | -434K | -1.03M | -5.58M | -299K | -1.6M | |||||
EBT | 34.32M | 45.58M | 50.68M | 51.55M | 47.66M | |||||
Gross Profit | - | - | - | - | 78.21M | |||||
D&A | 717K | 741K | 1.09M | 1.15M | 985K | |||||
Operating Income | - | - | - | - | 40.53M | |||||
Net Income | 20.88M | 30.6M | 35.64M | 36.17M | 33.92M |
| Fiscal Period: June | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Ireland | - | - | - | - | 52.51M | |||||
| - | - | - | - | 40.72M | ||||||
United States | - | - | - | - | 40.72M | |||||
| - | - | - | - | 791K | ||||||
Rest of The World | - | - | - | - | 791K | |||||
Europe and USA | 60.14M | 72.28M | - | - | - | |||||
| - | - | - | - | 52.51M | ||||||
Europe & USA Excl. Switzerland | - | - | 81.48M | 86.72M | - | |||||
Switzerland and Others | 5.58M | 6.04M | 6.7M | 8.3M | - | |||||
Europe | - | - | - | - | - | |||||
Total Assets | 144M | 194M | 9.06M | 8.78M | 10.46M |
Select your edition
All financial news and data tailored to specific country editions
